We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Agnico Eagle Mines
AEM
$90.5B
| $1.15M | ﹤0.01% |
27,174
| – | – |
|
2652
Bridgewater Bancshares
BWB
$603M
| $1.15M | ﹤0.01% |
69,686
-1,554
| -2% | -$26.6K |
|
2653
Cadre Holdings
CDRE
$1.41B
| $1.14M | ﹤0.01% |
47,469
+3,297
| +7% | +$80.7K |
|
2654
Destination XL Group
DXLG
$35.4M
| $1.14M | ﹤0.01% |
212,156
-9,199
| -4% | -$43.8K |
|
2655
Corsair Gaming
CRSR
$1.55B
| $1.14M | ﹤0.01% |
100,423
-437
| -0.4% | -$6.27K |
|
2656
Definitive Healthcare
DH
$75.3M
| $1.14M | ﹤0.01% |
73,382
+4,639
| +7% | +$102K |
|
2657
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $1.14M | ﹤0.01% |
40,337
-2,724
| -6% | -$77.1K |
|
2658
OneWater Marine
ONEW
$201M
| $1.14M | ﹤0.01% |
37,721
+749
| +2% | +$27.4K |
|
2659
Noodles & Co
NDLS
$107M
| $1.13M | ﹤0.01% |
30,144
-11,783
| -28% | -$468K |
|
2660
Vuzix
VUZI
$224M
| $1.13M | ﹤0.01% |
194,931
+17,370
| +10% | +$134K |
|
2661
Primis Financial Corp
FRST
$404M
| $1.13M | ﹤0.01% |
92,958
-663
| -0.7% | -$8.77K |
|
2662
Instil Bio
TIL
$50.3M
| $1.12M | ﹤0.01% |
11,599
-134
| -1% | -$15.3K |
|
2663
First Watch Restaurant Group
FWRG
$766M
| $1.12M | ﹤0.01% |
77,475
+14,370
| +23% | +$233K |
|
2664
Mitek Systems
MITK
$834M
| $1.12M | ﹤0.01% |
122,376
-1,440
| -1% | -$14.5K |
|
2665
Aura Biosciences
AURA
$826M
| $1.12M | ﹤0.01% |
61,724
+497
| +0.8% | +$7.52K |
|
|
VXRT
2666
DELISTED
Vaxart
VXRT
| $1.12M | ﹤0.01% |
513,297
-4,845
| -0.9% | -$16.7K |
|
2667
Tucows
TCX
$175M
| $1.12M | ﹤0.01% |
29,862
-117
| -0.4% | -$5.37K |
|
2668
Seneca Foods Class A
SENEA
$1.21B
| $1.12M | ﹤0.01% |
22,160
-1,663
| -7% | -$91.5K |
|
2669
Citizens & Northern Corp
CZNC
$455M
| $1.12M | ﹤0.01% |
46,172
-1,466
| -3% | -$35.8K |
|
2670
MiMedx Group
MDXG
$633M
| $1.11M | ﹤0.01% |
388,550
-10,999
| -3% | -$39.1K |
|
|
STER
2671
DELISTED
Sterling Check Corp. Common Stock
STER
| $1.11M | ﹤0.01% |
63,191
-634
| -1% | -$12.6K |
|
2672
Esquire Financial Holdings
ESQ
$1.14B
| $1.11M | ﹤0.01% |
29,636
-550
| -2% | -$20.5K |
|
|
CVT
2673
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $1.11M | ﹤0.01% |
211,547
-86,789
| -29% | -$493K |
|
2674
ALX Oncology
ALXO
$290M
| $1.11M | ﹤0.01% |
115,621
-1,198
| -1% | -$14K |
|
2675
Purple Innovation
PRPL
$41.7M
| $1.1M | ﹤0.01% |
10,887
-761
| -7% | -$66.1K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.